MiMedx Group, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent
MiMedx Group, Inc. (MDXG) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent of 0.10% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther · last filed 2026-02-25
- MiMedx Group, Inc. effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2025 was 0.10%.
- MiMedx Group, Inc. effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2016 was 0.04%, a 93.65% decline from fiscal 2015.
- MiMedx Group, Inc. effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2015 was 0.63%, a 88.73% decline from fiscal 2014.
- MiMedx Group, Inc. effective income tax rate reconciliation, nondeductible expense, other, percent for fiscal 2014 was 5.59%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent 12 month |
|---|---|
| 2025-12-31 | 0.10% 10-K · filed 2026-02-25 |
| 2016-12-31 | 0.04% 10-K · filed 2017-03-01 |
| 2015-12-31 | 0.63% 10-K · filed 2017-03-01 |
| 2014-12-31 | 5.59% 10-K · filed 2017-02-22 |
| 2013-12-31 | 0.00% 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |